Journey Medical Corp (DERM)

Finanzdaten der Journey Medical Corp-Aktie (DERM)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	101.14% 34.54	17.17	12.21	15.97	16.12
Cost Of Revenue	17.23% 6.429	7.767	6.449	7.718	7.221
Gross Profit	198.88% 28.11	9.405	5.764	8.248	8.895
Operating Expenses	36.31% 10.87	17.06	15.32	18.24	18.39
Interest Income/Expense	64.55% 0.268	0.756	0.65	0.617	0.559
Benefits Costs and Expenses	30.86% 17.66	25.54	22.35	26.59	26.19
Costs And Expenses	30.34% 17.29	24.82	21.77	25.96	25.61
Operating Income/Loss	325.34% 17.25	-7.653	-9.561	-9.995	-9.492
Nonoperating Income/Loss	49.15% -0.361	-0.71	-0.575	-0.634	-0.578
Income/Loss From Continuing Operations Before Tax	301.89% 16.88	-8.363	-10.14	-10.63	-10.07
Income Tax Expense/Benefit	0.095	-	-	0.013	0.01
Income/Loss From Continuing Operations After Tax	300.75% 16.79	-8.363	-10.14	-10.64	-10.08
Net Income/Loss	300.75% 16.79	-8.363	-10.14	-10.64	-10.08
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2.28% 18.42	18.01	17.81	0.0667	17.62
Diluted Average Shares	16.83% 21.03	18.01	17.81	0.0667	17.62
Basic Earnings Per Share	297.83% 0.91	-0.46	-0.57	-0.60	-0.57
Diluted Earnings Per Share	273.91% 0.80	-0.46	-0.57	-0.60	-0.57
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-